270 related articles for article (PubMed ID: 2189516)
41. A phase II/III double-blind, dose-finding clinical trial of a combination of mefloquine, sulfadoxine, and pyrimethamine (Fansimef) in falciparum malaria.
de Souza JM; Sheth UK; Wernsdorfer WH; Trigg PI; Doberstyn EB
Bull World Health Organ; 1987; 65(3):357-61. PubMed ID: 3311438
[TBL] [Abstract][Full Text] [Related]
42. Kenyan chloroquin, fansidar and quninine resistant P. Falciparum.
Turner GD
Cent Afr J Med; 1984 Jul; 30(7):136-7. PubMed ID: 6386173
[No Abstract] [Full Text] [Related]
43. Chemosuppression of malaria by the triple combination mefloquine/sulfadoxine/pyrimethamine: a field trial in an endemic area in Malaysia.
Navaratnam V; Mohamad M; Hussain S; Kumar A; Jamaludin A; Sulaiman I; Mahsufi S; Selliah K
Trans R Soc Trop Med Hyg; 1989; 83(6):755-9. PubMed ID: 2694509
[TBL] [Abstract][Full Text] [Related]
44. Fansidar resistant Plasmodium falciparum infection in Surinam.
Oostburg BF; Jozefzoon LM
Trop Geogr Med; 1983 Sep; 35(3):243-7. PubMed ID: 6359597
[TBL] [Abstract][Full Text] [Related]
45. Treatment failure of falciparum malaria with Fansidar in Tawau Sabah. January-June, 1982.
Tan Heng Soon ; Tan Puay Eng
Med J Malaysia; 1983 Sep; 38(3):217-23. PubMed ID: 6369092
[No Abstract] [Full Text] [Related]
46. Extension of multiple drug resistant Plasmodium falciparum malaria in Africa: report of a Central African case.
Belec L; Bouree P; Testa J; Delmont J; Quenum B; Georges AJ
Biomed Pharmacother; 1989; 43(9):699-702. PubMed ID: 2696567
[TBL] [Abstract][Full Text] [Related]
47. Qinghaosu, mefloquine, and pyrimethamine-sulfadoxine in falciparum malaria.
Arnold K
Lancet; 1985 Mar; 1(8430):704. PubMed ID: 2858655
[No Abstract] [Full Text] [Related]
48. Mefloquine, sulfadoxine, and pyrimethamine in the treatment of symptomatic falciparum malaria: a double-blind trial for determining the most effective dose.
Harinasuta T; Bunnag D; Vanijanond S; Charoenlarp P; Suntharasmai P; Chitamas S; Sheth UK; Wernsdorfer WH
Bull World Health Organ; 1987; 65(3):363-7. PubMed ID: 3311439
[TBL] [Abstract][Full Text] [Related]
49. Need for malaria prophylaxis by travelers to areas with chloroquine-resistant Plasmodium falciparum.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1986 Jan; 35(2):21-22, 27. PubMed ID: 3001495
[No Abstract] [Full Text] [Related]
50. In vitro susceptibility of Plasmodium falciparum to chloroquine, amodiaquine, quinine, mefloquine, and sulfadoxine/pyrimethamine in Equatorial Guinea.
Benito A; Roche J; Molina R; Amela C; Alvar J
Am J Trop Med Hyg; 1995 Nov; 53(5):526-31. PubMed ID: 7485712
[TBL] [Abstract][Full Text] [Related]
51. [The efficacy of and tolerance for fansimef in the treatment of tropical malaria in the south of the Socialist Republic of Vietnam].
Shcherbakov AM; Rabinovich SA; Chin KA; Nguyen VK; Chan VB; Dadasheva NR; Sokhanenkova TL; Nguyen VT; Vu TT; Vu C
Med Parazitol (Mosk); 1990; (4):7-9. PubMed ID: 2233545
[TBL] [Abstract][Full Text] [Related]
52. Tolerability of long-term malaria prophylaxis with the combination mefloquine + sulfadoxine + pyrimethamine (Fansimef): results of a double blind field trial versus chloroquine in Nigeria.
Kollaritsch H; Stemberger H; Mailer H; Kremsner P; Kollaritsch R; Leimer R; Wiedermann G
Trans R Soc Trop Med Hyg; 1988; 82(4):524-9. PubMed ID: 2908258
[TBL] [Abstract][Full Text] [Related]
53. Treatment of falciparum malaria with quinne and tetracycline or combined mefloquine/sulfadoxine/pyrimethamine on the Thai-Kampuchean border.
Meek SR; Doberstyn EB; Gaüzère BA; Thanapanich C; Nordlander E; Phuphaisan S
Am J Trop Med Hyg; 1986 Mar; 35(2):246-50. PubMed ID: 3513642
[TBL] [Abstract][Full Text] [Related]
54. Multiple drug resistant Plasmodium falciparum malaria in a pregnant indigenous Zambian woman.
Rolfe M
Trans R Soc Trop Med Hyg; 1988; 82(4):554-7. PubMed ID: 3076712
[TBL] [Abstract][Full Text] [Related]
55. RII and RIII type resistance of Plasmodium falciparum to combination of mefloquine and sulfadoxine/pyrimethamine in Indonesia.
Hoffman SL; Rustama D; Dimpudus AJ; Punjabi NH; Campbell JR; Oetomo HS; Marwoto HA; Harun S; Sukri N; Heizmann P
Lancet; 1985 Nov; 2(8463):1039-40. PubMed ID: 2865518
[TBL] [Abstract][Full Text] [Related]
56. Fansimef [Fansidar plus mefloquine] is effective treatment for imported malaria in New Zealand.
Ellis-Pegler RB; Beeching NJ; Eales M; Fraser AG; Wells AU
Aust N Z J Med; 1988 Aug; 18(5):733-4. PubMed ID: 3072955
[No Abstract] [Full Text] [Related]
57. Falciparum malaria treated with a fixed combination of mefloquine, sulfadoxine and pyrimethamine: a field study in adults in Burma.
Tin F; Hlaing N; Tun T; Win S; Lasserre R
Bull World Health Organ; 1985; 63(4):727-30. PubMed ID: 2935320
[TBL] [Abstract][Full Text] [Related]
58. Combination of mefloquine with sulfadoxine-pyrimethamine compared with two sulfadoxine-pyrimethamine combinations in malaria chemoprophylaxis.
Win K; Thwe Y; Lwin TT; Win K
Lancet; 1985 Sep; 2(8457):694-5. PubMed ID: 2863679
[No Abstract] [Full Text] [Related]
59. Chloroquine-resistant falciparum malaria from East Africa.
Bhattacharya DN; Hall AP
J Trop Med Hyg; 1986 Dec; 89(6):291-4. PubMed ID: 3543385
[TBL] [Abstract][Full Text] [Related]
60. Resistance of Plasmodium falciparum in vivo to 3 days' treatment with quinine and single-dose Fansidar.
Al-Yaman F; Genton B; Mokela D; Alpers MP
P N G Med J; 1994 Mar; 37(1):54-6. PubMed ID: 7863730
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
